Christian Klemt
Net Worth
Last updated:
What is Christian Klemt net worth?
The estimated net worth of Mr. Christian Klemt is at least $6,372,699 as of 9 Dec 2024. He owns shares worth $2,547,375 as insider, has earned $1,077,124 from insider trading and has received compensation worth at least $2,748,200 in uniQure N.V..
What is the salary of Christian Klemt?
Mr. Christian Klemt salary is $392,600 per year as Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site in uniQure N.V..
How old is Christian Klemt?
Mr. Christian Klemt is 52 years old, born in 1973.
What stocks does Christian Klemt currently own?
As insider, Mr. Christian Klemt owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| uniQure N.V. (QURE) | Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site | 166,713 | $15.28 | $2,547,375 |
What does uniQure N.V. do?
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease; AMT-060, which is in Phase I/II clinical trial for the treatment of hemophilia B; AMT-210, a product candidate for the treatment of Parkinson's disease; AMT-260 for temporal lobe epilepsy; AMT-240, a preclinical product candidate for the treatment of autosomal dominant Alzheimer's disease; and AMT-161 for the treatment of amyotrophic lateral sclerosis. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
Christian Klemt insider trading
uniQure N.V.
Mr. Christian Klemt has made 22 insider trades between 2018-2024, according to the Form 4 filled with the SEC. Most recently he sold 1,796 units of QURE stock worth $13,560 on 9 Dec 2024.
The largest trade he's ever made was exercising 15,906 units of QURE stock on 26 Feb 2024. As of 9 Dec 2024 he still owns at least 166,713 units of QURE stock.
uniQure N.V. key executives
uniQure N.V. executives and other stock owners filed with the SEC:
- Dr. Alexander E. Kuta Ph.D. (65) Executive Vice President of Quality & Regulatory
- Dr. Ricardo Dolmetsch Ph.D. (56) Pres of R&D
- Mr. Christian Klemt (52) Chief Financial Officer, Principal Financial Officer & GM of Amsterdam Site
- Mr. Matthew Craig Kapusta (53) Chief Executive Officer & Executive Director